SAFE WKN: A3D6CP ISIN: FR001400F1V2 Forum: Aktien User: Pass_Buddi

Die großen Volumina würden sich normalerweise durch einen großen Anstieg widerspiegeln, aber nicht wenn so viele Verkäufer die Aktie weiterhin verramschen. Verstehen kann ich das nicht, denn die Großinvestoren hätten heute Abend bestimmt auch 0,0006€ oder mehr bezahlt.

meine güte ......also gut ........hab ich halt grad nochmal 500000 gekauft ....... ess ich halt nur noch toastbrot......18:58:09.361 0,0006 € 500.000

morgen geht es los. Wirst es verkraften, nur ein Zuschauer zu sein?

mein fehler ......sorry.......

Aber warum sieht man nichts im Kurs wenn so viel gekauft wurde?

hahaha leider nicht ...... ich bin schon im + .....tralalalalaaaaaaaaaaaaaaaaaaa

doch net bei dem spread gerade ....... bist du irre ?

ich muss wahrscheinlich morgen in Paris nachlegen. Ist schon beeindruckend, dass zum Schluss mit hohem Volumen aufgekauft wird

Hättest gern oder wird aber so nicht kommen

Moinsen! Verliert ihr gerade alle schön euer Geld?

So Frankfurt 833.333 Stück sind durch

Bin dabei ich Kauf jetzt ein für 500 Euro

Ich muss mir sowas im Leben suchen. Sonst verzweifelt man doch nur noch. Haha....

okayyyy..... 😂😂😂😂😂 es sind die kleinen dinge des lebens die faszinieren

Kann das bitte einer bewerten…

FIRST-HALF 2024 SALES Fleurieux-sur-l'Arbresle - Frankreich - July 29, 2024, 6.00 p.m. The group Safe (FR001400F1V2 – ALSAF) announces consolidated sales for 1st half 2024. In k€ First-half 2024* First-half 2023 % ändert sich Sales 2.587 2.909 - 11,1% Safe Orthopaedics 1.303 1 726 - 24,5% Safe Medical 1 284 1 183 + 8,5% * Unaudited 2024 figures The Safe Group's consolidated sales for the 1st half of 2024 came to €2.6 million, maintaining a good level. Over the period, the new management team implemented a large-scale plan to transform the Group. Strategic decisions have been taken, including the implementation of a new sales dynamic, the first effects of which will be visible from the second half of 2024. Half-year sales for Safe Orthopaedics came to €1.3 million, slightly above Group expectations, compared with €1.7 million in the first half of 2023. Safe Medical sales continued to grow, reaching €1.3 million, up 8.5% on the same period last year. As a reminder, the Group has been in receivership since September 4, 2023, and has obtained an extension of its observation period until November 4, 20241. Beyond this 3rd observation period, validating the strategy, the Safe Group has achieved several successes, including the signature of a major partnership with a group of Californian hospitals, and the successful first implementations of the Sycamore device in Switzerland. Above all, the reorganization of the sales network in France, effective since May 2024, has enabled sales to start up in a dozen new hospitals and clinics. The operational and financial reorganization undertaken by the Group should enable it to regain its competitiveness and return to profitable growth. At the same time, the management team is continuing to draw up the recovery plans 2which will be examined by the Commercial Court at a hearing scheduled for September 20, 2024. Über Safe Group Safe Group is a French medical technology group that brings together Safe Orthopaedics, a pioneer in ready-to-use technologies for spine pathologies, and Safe Medical (formerly LCI Medical), a medical device subcontractor for orthopedic surgeries. Die Gruppe beschäftigt ungefähr 100 Menschen. Safe Orthopaedics develops and manufactures kits combining sterile implants and ready-to-use instruments, available at any time to the surgeon. These technologies are part of a minimally invasive approach aimed at reducing the risks of contamination and infection, in the interest of the patient and with a positive impact on hospitalization times and costs. Protected by 15 patent families, SteriSpineTM kits are CE marked and FDA approved. Safe Orthopaedics has subsidiaries in the United Kingdom, Germany, the United States. Für weitere Informationen: www.safeorthopaedics.com Safe Medical produces implantable medical devices and ready-to-use instruments. It has an innovation center and two production sites in France and in Tunisia, offering numerous industrial services: industrialization, machining, finishing and sterile packaging. Für weitere Informationen: www.safemedical.fr